Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Molecular Cancer Therapeutics|February 2, 2013
EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristicsMaria E Arcila, Khedoudja Nafa, Jamie E Chaft, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
The molecular landscape of extraskeletal osteosarcoma: A clinicopathological and molecular biomarker studyGeorge Jour, Lu Wang, Sumit Middha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagiaMark E Robson, Emily Glogowski, Gunhild Sommer, et al.
Blood|November 25, 2003
Mutations of the PML tumor suppressor gene in acute promyelocytic leukemiaCarmela Gurrieri, Khedoudja Nafa, Taha Merghoub, et al.
Human Pathology|November 1, 2019
RUNX2 (6p21.1) amplification in osteosarcomaSounak Gupta, Tatsuo Ito, Deepu Alex, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomasMaria E Arcila, Jamie E Chaft, Khedoudja Nafa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2011
Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assayMaria E Arcila, Geoffrey R Oxnard, Khedoudja Nafa, et al.
The Journal of Molecular Diagnostics : JMD|December 28, 2019
Reliable Clinical MLH1 Promoter Hypermethylation Assessment Using a High-Throughput Genome-Wide Methylation Array PlatformJamal K Benhamida, Jaclyn F Hechtman, Khedoudja Nafa, et al.
Pageof 9